(Q34728381)

4 August 2017

title

Postmarketing surveillance of adverse drug reactions: problems and solutions (English)

1 reference

4 August 2017

Lortie FM

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 1986

1 reference

Canadian Medical Association Journal

4 August 2017

published in

1 reference

4 August 2017

volume

135

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

27-32

1 reference

The Environment and Disease: Association or Causation?

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Statistical aspects of the analysis of data from retrospective studies of disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Record linkage for drug monitoring

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

A method for estimating the probability of adverse drug reactions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

How good are the data? Reliability of one health care data bank

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

The case-control study. A practical review for the clinician

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Discovery of new adverse drug reactions. A review of the Food and Drug Administration's spontaneous reporting system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Medicaid drug-event data: an emerging tool for evaluation of drug risk.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Retrospective studies. A review for the clinician

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and "retrospective" research.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

A study of adverse reaction algorithms in a drug surveillance program.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Toward the operational identification of adverse drug reactions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Methodologic problems and standards in case-control research

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

The case control study: The problem and the prospect

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Aspects of standardization as applied to the assessment of drug-event associations.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

Matching and design efficiency in retrospective studies

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1491132

26 October 2018

Adverse drug reactions

1 reference

12 December 2020

Legal perspectives in causality assessment

1 reference

12 December 2020

Adverse drug effects: evaluation of four secondary reference sources

1 reference

12 December 2020

Adverse drug reaction monitoring: doing it the French way

1 reference

12 December 2020

The ambiguity of adverse drug reactions

1 reference

12 December 2020

Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods

1 reference

12 December 2020

The epidemiological evaluation of drugs

1 reference

12 December 2020

Cimetidine postmarket outpatient surveillance program. Interim report on phase I

1 reference

12 December 2020

Postmarketing studies of drug efficacy

1 reference

12 December 2020

Postmarketing follow-up: physicians have key role

1 reference

12 December 2020

Long-term surveillance for adverse effects of antihypertensive drugs

1 reference

12 December 2020

Is better feedback a major stimulus to spontaneous adverse reaction monitoring?

1 reference

12 December 2020

1 reference

12 December 2020

The computerized on-line Medicaid pharmaceutical analysis and surveillance system: a new resource for postmarketing drug surveillance

1 reference

12 December 2020

Identifiers

PMC publication ID

1491132

1 reference

4 August 2017

1 reference